Search

Search Constraints

You searched for: Author/Creator Belcaid, Zineb

Search Results

1. Contrasting impact of corticosteroids on anti-PD-1 immunotherapy efficacy for tumor histologies located within or outside the central nervous system. (2nd December 2018)

2. Expression of LAG‐3 and efficacy of combination treatment with anti‐LAG‐3 and anti‐PD‐1 monoclonal antibodies in glioblastoma. Issue 12 (24th September 2018)

3. Ganetespib radiosensitization for liver cancer therapy. Issue 4 (2nd April 2016)

4. Genome‐wide investigation of intragenic DNA methylation identifies ZMIZ1 gene as a prognostic marker in glioblastoma and multiple cancer types. Issue 12 (9th August 2019)

6. Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapy. Issue 1 (3rd February 2020)

7. Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapy. Issue 2 (3rd February 2020)

8. Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy. Issue 6 (10th June 2022)

9. TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM. (3rd August 2018)